Login

Ngopi & Career : Company ONE XOX SDN BHD | Ng Kok Heng, CEO, XOX BhdXOX:KLS 00:10:00

Share On Facebook Share On Twitter

Ng Kok Heng is the Group Chief Executive Officer at XOX BHD.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Outcrop Silver and Gold: High-Grade Discoveries in Colombia
00:10:00
Globex Mining Enterprises Inc at PDAC 2022 featuring MiningIR | Jack Stoch, CEO, Globex Mining Enterprises Inc. (IE)
00:10:00
Economist David Gladstone Forecasts Prolonged Elevated Produce Prices Pending Further Economic Opening|David J. Gladstone, Chairman & CEO,Gladstone Commercial Corporation
00:10:00
Significant Investments in Solar and Wind Energize Growth | Patrick Decostre, CEO, Boralex Inc.
00:10:00
DS Smith Purpose: Insights from CEO Miles Roberts | Miles W. Roberts - CEO of DS Smith
00:10:00
Adapting Development Finance: Tellef Thorleifsson on Global Shifts and Africa Engagement | Tellef Thorleifsson, CEO, Norfund.
00:10:00
Apollo's Path to Dominance in Alternative Investments | Marc Rowan, CEO, Apollo Global Management.
00:10:00
Green Mining Initiative Funds Awarded to MIRARCO | Nadia Mykytczuk - CEO of MIRARCO
00:10:00
Shining a Light on Tomorrow's Titans: The Most Compelling Startups|Arash Ferdowsi,Angel Investor,Arash Ferdowsi
00:10:00
Stan Miranda: Merging Strategic Insights with the Endowment Model at Partners Capital
00:10:00
Saudi Minister Discusses Supply Chain Investments at FII Conference | Bandar Alkhorayef - Minister of Industry and Mineral Resources
00:10:00
A Vision for the Future: Dr. Barb Jones on Leading CLSI's Global Impact in Diagnostic Standards

© 2017 - Neuhu+